{"log_id": 3357485660339008067, "direction": 0, "words_result_num": 35, "words_result": [{"probability": {"variance": 1.8e-05, "average": 0.996652, "min": 0.989159}, "location": {"width": 134, "top": 140, "height": 30, "left": 121}, "words": "【不良反应】"}, {"probability": {"variance": 6e-06, "average": 0.999029, "min": 0.985261}, "location": {"width": 946, "top": 192, "height": 40, "left": 162}, "words": "临床试验资料为确定药物可能引起的不良事件及其近似发生率提供了一定的依据。由于临"}, {"probability": {"variance": 4e-06, "average": 0.998607, "min": 0.991649}, "location": {"width": 995, "top": 247, "height": 42, "left": 113}, "words": "床试验的条件变化大,试验中观察到的一个药物不良事件的发生率不能直接与另一个药物的临"}, {"probability": {"variance": 5e-06, "average": 0.998677, "min": 0.991654}, "location": {"width": 835, "top": 304, "height": 40, "left": 115}, "words": "床试验观察到的不良事件发生率相比较,也可能不能反映临床中的实际发生率"}, {"probability": {"variance": 4.5e-05, "average": 0.996963, "min": 0.967165}, "location": {"width": 928, "top": 357, "height": 39, "left": 164}, "words": "有关甲磺酸阿帕替尼应用于晚期胃癌的不良反应信息主要来自一项Ⅲ期、多中心、随机"}, {"probability": {"variance": 0.002692, "average": 0.98669, "min": 0.65458}, "location": {"width": 994, "top": 412, "height": 40, "left": 115}, "words": "安慰剂对照临床试验(n=267)。受试者均为二线化疗失败的晚期胃癌患者,试验中排除了ECOG"}, {"probability": {"variance": 1.5e-05, "average": 0.998232, "min": 0.976627}, "location": {"width": 986, "top": 467, "height": 41, "left": 123}, "words": "(东部肿瘤协作组织)体力状态评分为2分及以上患者、有胃肠道出血倾向的患者、药物不可"}, {"probability": {"variance": 0.000249, "average": 0.995092, "min": 0.903733}, "location": {"width": 969, "top": 521, "height": 40, "left": 115}, "words": "控制的高血压患者、凝血功能异常患者、尿蛋白阳性患者、胆红素≥1.25倍正常值上限的患者"}, {"probability": {"variance": 0.001115, "average": 0.990879, "min": 0.774522}, "location": {"width": 994, "top": 576, "height": 38, "left": 116}, "words": "4周内进行过大手术伤口未愈合的患者。176例患者服用本品850mgqd治疗。72%的受试者接"}, {"probability": {"variance": 8.7e-05, "average": 0.997117, "min": 0.940677}, "location": {"width": 983, "top": 629, "height": 39, "left": 117}, "words": "受了2个周期或以上的治疗(28天为一个周期)。试验组和安慰剂组不良反应(根据美国国"}, {"probability": {"variance": 0.007687, "average": 0.971075, "min": 0.442675}, "location": {"width": 969, "top": 683, "height": 40, "left": 115}, "words": "家癌症研究所通用不良反应分级标准 nci-ctc AE3.0判断)发生率分别为92.05%和71.43%"}, {"probability": {"variance": 0.000705, "average": 0.991804, "min": 0.829107}, "location": {"width": 990, "top": 738, "height": 40, "left": 117}, "words": "34级不良反应的发生率分别为51.70%和24.18%。常见不良反应(发生率≥5%)中,试验组"}, {"probability": {"variance": 0.00937, "average": 0.974305, "min": 0.449907}, "location": {"width": 992, "top": 793, "height": 41, "left": 118}, "words": "与对照组发生率有统计学差异的不良反应包括血液学毒性(白细胞减少、粒细胞减少、血小板"}, {"probability": {"variance": 0.000125, "average": 0.996708, "min": 0.927233}, "location": {"width": 990, "top": 845, "height": 41, "left": 118}, "words": "减少)和非血液学毒性(蛋白尿、高血压、手足综合征、乏力、声音嘶哑)。试验组与对照组"}, {"probability": {"variance": 0.003655, "average": 0.986212, "min": 0.610053}, "location": {"width": 917, "top": 900, "height": 38, "left": 121}, "words": "的严重不良反应发生率分别为6.25%和6.59%,常见的严重不良反应均为上消化道出血"}, {"probability": {"variance": 0.003504, "average": 0.98679, "min": 0.624378}, "location": {"width": 941, "top": 954, "height": 39, "left": 168}, "words": "另外一项在二线治疗失败的晚期胃癌中进行的多中心、随机、双盲、安慰剂平行对照的Ⅱ"}, {"probability": {"variance": 0.006684, "average": 0.980007, "min": 0.435199}, "location": {"width": 981, "top": 1008, "height": 41, "left": 121}, "words": "期临床研究(n141)提供了支持数据。该研究中接受850mgqd治疗的受试者共47例。研究人"}, {"probability": {"variance": 0.006069, "average": 0.977899, "min": 0.618584}, "location": {"width": 961, "top": 1063, "height": 40, "left": 120}, "words": "群基线特征与1期相似。850mgqd组有35例患者接受了2个周期或以上的治疗(28天为"}, {"probability": {"variance": 0.00762, "average": 0.969204, "min": 0.518133}, "location": {"width": 991, "top": 1113, "height": 45, "left": 121}, "words": "个周期)。850mgqd组和安慰剂组不良反应(根据NCI- CTC AE3.0判断)发生率分别为78.72%"}, {"probability": {"variance": 0.003164, "average": 0.976113, "min": 0.74655}, "location": {"width": 625, "top": 1172, "height": 38, "left": 121}, "words": "和56.25%,3/4级不良反应发生率分别为34.04%和16.67%"}, {"probability": {"variance": 5e-06, "average": 0.998401, "min": 0.990945}, "location": {"width": 921, "top": 1223, "height": 41, "left": 169}, "words": "表2列出了两项研究合并的安全性数据库中发生率≥5%的不良反应以及发生率≥2%的"}, {"probability": {"variance": 0.018531, "average": 0.946077, "min": 0.586098}, "location": {"width": 160, "top": 1288, "height": 29, "left": 122}, "words": "3/4级不良反应"}, {"probability": {"variance": 0.003372, "average": 0.97825, "min": 0.739337}, "location": {"width": 513, "top": 1329, "height": 36, "left": 356}, "words": "表2,Ⅱ期、Ⅲ期临床研究中发生率≥5%的不良反应及"}, {"probability": {"variance": 2.9e-05, "average": 0.997275, "min": 0.978683}, "location": {"width": 282, "top": 1374, "height": 27, "left": 479}, "words": "发生率≥2%的34级不良反应"}, {"probability": {"variance": 0.005789, "average": 0.952184, "min": 0.71137}, "location": {"width": 188, "top": 1420, "height": 26, "left": 509}, "words": "850mgqd组(N=223"}, {"probability": {"variance": 0.003021, "average": 0.970842, "min": 0.814822}, "location": {"width": 156, "top": 1417, "height": 26, "left": 789}, "words": "安慰剂组(N=139"}, {"probability": {"variance": 0, "average": 0.999853, "min": 0.999751}, "location": {"width": 47, "top": 1465, "height": 26, "left": 330}, "words": "症状"}, {"probability": {"variance": 0, "average": 0.999842, "min": 0.999711}, "location": {"width": 47, "top": 1462, "height": 27, "left": 510}, "words": "全部"}, {"probability": {"variance": 0.000568, "average": 0.971952, "min": 0.937571}, "location": {"width": 57, "top": 1463, "height": 24, "left": 630}, "words": "3/4级"}, {"probability": {"variance": 0, "average": 0.999223, "min": 0.998822}, "location": {"width": 47, "top": 1460, "height": 26, "left": 774}, "words": "全部"}, {"probability": {"variance": 5.8e-05, "average": 0.987936, "min": 0.975302}, "location": {"width": 57, "top": 1460, "height": 24, "left": 909}, "words": "3/4级"}, {"probability": {"variance": 0.000599, "average": 0.930301, "min": 0.911709}, "location": {"width": 46, "top": 1510, "height": 21, "left": 510}, "words": "n(%)"}, {"probability": {"variance": 0.000396, "average": 0.972706, "min": 0.947355}, "location": {"width": 47, "top": 1509, "height": 21, "left": 636}, "words": "n(%)"}, {"probability": {"variance": 0.001409, "average": 0.954748, "min": 0.910504}, "location": {"width": 50, "top": 1507, "height": 23, "left": 775}, "words": "n(%)"}, {"probability": {"variance": 0.000942, "average": 0.958695, "min": 0.923691}, "location": {"width": 41, "top": 1506, "height": 22, "left": 916}, "words": "n(%"}], "language": 3}